CCHWF:OTC-Columbia Care Inc (USD)

COMMON STOCK | Others | OTC

Last Closing Price

USD 4.25

Change

-0.09 (-1.96)%

Market Cap

N/A

Volume

0.17M

Average Target Price

USD 9.50 (+123.53%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-12-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
CSTNL iShares VII Public Limited Com..

+3.10 (+0.85%)

USD32.85B 19.50 N/A
DAXXF iShares Core DAX UCITS ETF (DE..

N/A

USD22.34B N/A N/A
IISHF iShares III Plc Emerging Mkts ..

N/A

USD9.10B N/A N/A
ZKBGF ZKB Gold ETF

N/A

USD8.96B N/A N/A
IHPCF iShares Public Limited Company..

+0.64 (+1.79%)

USD8.93B 19.50 N/A
CUYTF Etn. Fr. Colruyt NV

N/A

USD8.61B 20.58 10.33
CUYTY Etn. Fr. Colruyt NV

-0.14 (-0.95%)

USD8.17B 20.34 10.17
TOETF Tosei Corporation

N/A

USD7.70B 151.60 -597.40
EFMSF ETFS Metal Securities Limited ..

-6.32 (-3.55%)

USD7.39B N/A N/A
IUTSF iShares S&P/TSX 60 Index ETF

N/A

USD6.41B N/A N/A

ETFs Containing CCHWF

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Others)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 70.68% 86% B 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 70.68% 86% B 79% C+
Trailing 12 Months  
Capital Gain 102.38% 89% B+ 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 102.38% 89% B+ 83% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -3.08% N/A N/A 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.08% N/A N/A 31% F
Risk Return Profile  
Volatility (Standard Deviation) 8.66% N/A N/A 92% A-
Risk Adjusted Return -35.62% N/A N/A 23% F
Market Capitalization N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Others)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio N/A N/A N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A N/A N/A
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A N/A N/A
Return on Invested Capital N/A N/A N/A N/A N/A
Return on Assets N/A N/A N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials ()

Quarterly Financials ()

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike